Fan Xinxiang, Zhang Junhao, Zhu Honghao, Huang Foyang, Shadike Adili, Jiang Chun
Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
Guangdong Provincial Clinical Research Center for Urological Diseases, Guangzhou, China.
Transl Androl Urol. 2024 Sep 30;13(9):1775-1785. doi: 10.21037/tau-24-71. Epub 2024 Sep 26.
Stress urinary incontinence (SUI) remains a prevalent complication after Holmium Laser Enucleation of the Prostate (HoLEP). This retrospective analysis aims to delineate perioperative and anatomical determinants of SUI as observed on preoperative multiparametric magnetic resonance imaging (mpMRI) in patients subjected to HoLEP.
We reviewed 216 benign prostatic hyperplasia (BPH) cases managed via HoLEP by a singular urologist at Sun Yat-sen Memorial Hospital from January 2021 to September 2022. Comprehensive medical documentation, including age, body mass index (BMI), prostate volume (PV), total prostate-specific antigen (tPSA), and perioperative variables: operative time (OT), enucleated prostate volume (EPV), were assessed. Detailed analyses of preoperative prostate mpMRI scans were conducted to measure factors such as thickness of the posterior wall of the membranous urethral sphincter (TPWMUS), membranous urethral length (MUL), membranous urethral volume (MUV), and prostatic apex morphology.
The cohort encompassed 216 participants, among whom 45 (20.83%) experienced SUI subsequent to one month of HoLEP therapy. At three months, 23 individuals exhibited recovery, reducing the prevalence of SUI to 10.19%. By the six-month milestone, the incidence further declined to 1.38%, with 19 patients reporting normalization of continence. Binary logistic regression analysis identified OT, TPWMUS, and prostatic apex and membranous urethral overlap (PAOMU) emerged as independent risk factors for SUI, while MUV was identified as a protective factor.
The risk of SUI post-HoLEP is significantly associated with OT, TPWMUS, and PAOMU, while MUV imparting a protective effect.
压力性尿失禁(SUI)仍是钬激光前列腺剜除术(HoLEP)后常见的并发症。本回顾性分析旨在明确接受HoLEP治疗患者术前多参数磁共振成像(mpMRI)观察到的SUI围手术期及解剖学决定因素。
我们回顾了2021年1月至2022年9月在中山大学孙逸仙纪念医院由一位泌尿外科医生通过HoLEP治疗的216例良性前列腺增生(BPH)病例。评估了综合医疗记录,包括年龄、体重指数(BMI)、前列腺体积(PV)、总前列腺特异性抗原(tPSA)以及围手术期变量:手术时间(OT)、剜除前列腺体积(EPV)。对术前前列腺mpMRI扫描进行详细分析,以测量诸如膜性尿道括约肌后壁厚度(TPWMUS)、膜性尿道长度(MUL)、膜性尿道体积(MUV)和前列腺尖形态等因素。
该队列包括216名参与者,其中45名(20.83%)在HoLEP治疗1个月后出现SUI。3个月时,23人症状恢复,SUI患病率降至10.19%。到6个月时,发病率进一步降至1.38%,19名患者报告尿失禁恢复正常。二元逻辑回归分析确定OT、TPWMUS以及前列腺尖与膜性尿道重叠(PAOMU)是SUI的独立危险因素,而MUV是保护因素。
HoLEP术后SUI的风险与OT、TPWMUS和PAOMU显著相关,而MUV具有保护作用。